Association of ranibizumab (Lucentis®) or bevacizumab (Avastin®) with dexamethasone and triamcinolone acetonide: An in vitro stability assessment

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

Monica Bucciantini, Elisa Giannoni, Fabrizio Chiti et al. · Nature · 2002 · 2.4K citations

Life Sciences, Biochemistry, Molecular Biology +17

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

Carl D. Regillo, David M. Brown, Prema Abraham et al. · American Journal of Ophthalmology · 2008 · 862 citations

Medicine, Ophthalmology, Surgery +10

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 2

Prema Abraham, Huibin Yue, Laura Wilson · American Journal of Ophthalmology · 2010 · 443 citations

Medicine, Ophthalmology, Surgery +10

Protein Aggregates Seem to Play a Key Role Among the Parameters Influencing the Antigenicity of Interferon Alpha (IFN-α) in Normal and Transgenic Mice

Andrea Braun, Lia Kwee, Mark Labow et al. · Pharmaceutical Research · 1997 · 299 citations

Life Sciences, Immunology, Molecular Biology +10

TRIPLE THERAPY FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION

Albert J. Augustin, Stephan Puls, I. Offermann · Retina · 2007 · 193 citations

Medicine, Ophthalmology, Pharmacotherapy +17